The drug of preference is usually a statin since these drugs reduce CV events and CV mortality. Consider adding ezetimibe and PCSK9 inhibitors for patients with ASCVD who will be not at intention. For those who have non-diabetic hyperglycaemia, you might be suitable for your NHS Diabetes Prevention Programme. The https://red-coral-significance91357.glifeblog.com/26410775/top-latest-five-diabetes-physicians-urban-news